Skip to main content

Priebe Waldemar's Form 4 filing

CNS Pharmaceuticals, Inc. (CNSP) · filed Aug 1, 2023

Accession no.
0000897069-23-001044
Filed
Aug 1, 2023
Trade date
Dec 6, 2022-Mar 28, 2023
Filing delay
238 daysLate
Rule 10b5-1 plan
Checked

This filing lists 17 non-derivative transactions and 0 derivative transactions. Open-market sales total $133.1K. It was filed 238 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Priebe WaldemarCIK 000167851610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 6, 2022Common StockSSaleDisposed−5,500$2.47−$13,585245,605Indirect
Dec 7, 2022Common StockSSaleDisposed−5,500$2.46−$13,530240,105Indirect
Dec 8, 2022Common StockSSaleDisposed−5,500$2.40−$13,200234,605Indirect
Dec 9, 2022Common StockSSaleDisposed−2,798$2.43−$6,799.14231,807Indirect
Mar 10, 2023Common StockSSaleDisposed−5,000$1.29−$6,450226,807Indirect
Mar 13, 2023Common StockSSaleDisposed−5,000$1.30−$6,500221,807Indirect
Mar 14, 2023Common StockSSaleDisposed−5,000$1.35−$6,750216,807Indirect
Mar 15, 2023Common StockSSaleDisposed−5,000$1.22−$6,100211,807Indirect
Mar 16, 2023Common StockSSaleDisposed−5,000$1.24−$6,200206,807Indirect
Mar 17, 2023Common StockSSaleDisposed−5,000$1.13−$5,650201,807Indirect
Mar 20, 2023Common StockSSaleDisposed−5,000$1.08−$5,400196,807Indirect
Mar 21, 2023Common StockSSaleDisposed−5,000$1.10−$5,500191,807Indirect
Mar 22, 2023Common StockSSaleDisposed−5,000$1.08−$5,400186,807Indirect
Mar 23, 2023Common StockSSaleDisposed−10,000$1.08−$10,800176,807Indirect
Mar 24, 2023Common StockSSaleDisposed−5,000$1.08−$5,400171,807Indirect
Mar 27, 2023Common StockSSaleDisposed−5,000$1.09−$5,450166,807Indirect
Mar 28, 2023Common StockSSaleDisposed−10,000$1.04−$10,400156,807Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)